NCT04466449

Brief Summary

  1. 1.Determination the prevalence of Entamoeba histolytica infections among patients at Assiut University Hospitals presented with diarrhea/dysentery.
  2. 2.Evaluatation the role of different cultures in diagnosing Entamoeba .
  3. 3.Molecularly differentiation between Entamoeba species to monitor the true prevalence of E.histolytica .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
138

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 10, 2020

Completed
2.1 years until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

March 9, 2022

Status Verified

February 1, 2022

Enrollment Period

Same day

First QC Date

July 8, 2020

Last Update Submit

February 23, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determination the prevalence of Entamoeba histolytica infections among patients at Assiut University Hospitals presented with diarrhea/dysentery

    Different Methods for Detection and Identification of Entamoeba species in Assuit Governorate.

    2022

Interventions

stool sampleDIAGNOSTIC_TEST

A stool sample will be collected from each patient for diagnosis of Entamoeba

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male and female patients of different age groups with diarrhea/dysentery attending the outpatient clinics at Assiut University Hospitals

You may qualify if:

  • : Male and female patients of different age groups with diarrhea/dysentery attending the outpatient clinics at Assiut University Hospitals .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Youstina Talaat

Asyut, Egypt

RECRUITING

Central Study Contacts

Abeer Lsayed Mahmoud

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
YTalaatBasaly

Study Record Dates

First Submitted

July 8, 2020

First Posted

July 10, 2020

Study Start

September 1, 2022

Primary Completion

September 1, 2022

Study Completion

October 1, 2022

Last Updated

March 9, 2022

Record last verified: 2022-02

Locations